Tom Neuwirth, also known as Conchita Wurst, and Johannes Pietsch, also known as JJ, are launching a joint podcast on FM4. Starting February 22, 2026, they will discuss weekly under the title “Bussi ...

While many women swooned over Michael Bolton’s 1991 song, “When A Man Loves a Woman,” we can bet they didn’t know that the ...

Surging terrorism in Pakistan is posing complicated challenges meriting more focused counter efforts in addition to kinetic operations. Indoctrination of women for hardcore terrorist attacks like ...

Phase III study will be "sufficient and pivotal for registration in the U.S." Kiniksa Pharmaceuticals ( KNSA +1.56%) ...

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations ...

Did our AI summary help? Who is the man currently leading the Baloch Liberation Army and shaping the group’s recent wave of attacks on Pakistani security forces? Bashir Zeb has emerged as the most ...

The Baloch Liberation Army (BLA) on Sunday claimed it has detained 17 Pakistani soldiers, releasing 10 while giving the Pakistani government one week to arrange a prisoner swap for the remaining seven ...

UNITED NATIONS: Pakistan on Wednesday urged the United Nations Security Council (UNSC) to move swiftly to designate the banned Balochistan Liberation Army (BLA) as a terrorist organisation under its ...

Balochistan has experienced its largest-ever coordinated militant attacks, with the BLA separatist group storming security posts and towns in a dramatic escalation of a long-running insurgency.

REGENXBIO plans to work with FDA on a path forward with the goal of resubmitting the BLA ROCKVILLE, Md., Feb. 9, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that the U.S. Food ...

ISLAMABAD: A judicial magistrate on Monday ap­­proved a three-day physical remand of a man arrested for allegedly promoting the banned Balochistan Libera­tion Army (BLA) narrative on social media.

FDA issues Complete Response Letter for RGX-121 (clemidsogene lanparvovec) for treatment of Mucopolysaccharidosis II (MPS II) REGENXBIO (RGNX) plans to work with FDA on a path forward with the goal of ...